Search for: "May v. Amgen, Inc."
Results 1 - 20
of 298
Sorted by Relevance
|
Sort by Date
11 Aug 2017, 8:00 am
consolidated with Amgen Inc. v. [read post]
14 Dec 2017, 9:11 pm
By Andrew Williams -- Last June, in Sandoz Inc. v. [read post]
18 Oct 2023, 4:58 pm
In Amgen Inc. v. [read post]
2 Nov 2023, 11:32 am
In Baxalta Inc. v. [read post]
30 Aug 2023, 4:01 pm
” Thus, citing Genentech, Inc. v. [read post]
28 Feb 2013, 5:00 am
Supreme Court handed down its opinion in a securities class action case, Amgen Inc. v. [read post]
4 Mar 2013, 6:27 pm
In Amgen, Inc. v. [read post]
3 Oct 2023, 4:15 am
The Supreme Court decided Amgen Inc. v. [read post]
3 Oct 2023, 4:15 am
The Supreme Court decided Amgen Inc. v. [read post]
4 Mar 2013, 8:00 am
John Fund, Inc. v. [read post]
27 Feb 2013, 9:53 am
In Amgen Inc. v. [read post]
14 May 2007, 9:26 pm
**Separately,Mondaq covered the Judge Moore opinion in the inequitable conduct case of eSpeed, Inc. v. [read post]
18 Jan 2024, 5:14 pm
The post USPTO Issues “Reasonable” Guidance on Enablement Under Amgen v. [read post]
7 Mar 2023, 9:16 pm
Sanofi may be the most closely watched patent case since AMP v. [read post]
10 Sep 2023, 9:15 am
The Supreme Court’s decision in Amgen Inc. v. [read post]
10 Sep 2023, 9:15 am
The Supreme Court’s decision in Amgen Inc. v. [read post]
15 Sep 2009, 10:54 pm
Praxair, Inc. v. [read post]
31 May 2023, 9:43 am
Cir. 2021), the Supreme Court found Amgen's function and epitope defined PCSK9 antibody patents to lack enablement (Amgen Inc v Sanofi, No. 21-757). [read post]
17 May 2023, 9:00 pm
ShareOn Thursday, May 18, we live blogged as the court issued opinions in Amgen Inc. v. [read post]
28 Nov 2006, 6:14 am
Amgen Inc., v. [read post]